Prem S Shah Cvs Health Corp (CVS) insider trading activity

Prem S Shah is EVP and Pres-Pharm, Consumer W of CVS HEALTH Corp. Currently has a direct ownership of 42,034 shares of CVS, which is worth approximately $2.51 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 7,892 shares (Common Stock) at a price of $79.56 per share, resulting in proceeds of $627,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42K

2.67% 3M change

14.85% 12M change

Total Value Held $2.51 Million

Prem S Shah Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Payment of exercise price or tax liability	$627,887 $79.56 p/Share	7,892 Reduced 15.81%	42,034 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	15,082 Added 28.93%	37,057 Common Stock (restricted)
Feb 26 2024	SELL Payment of exercise price or tax liability	$19,948 $76.43 p/Share	261 Reduced 0.6%	43,185 Common Stock
Feb 16 2024	SELL Open market or private sale	$2,267,947 $76.95 p/Share	29,473 Reduced 42.57%	39,764 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	13,313 Added 16.13%	69,237 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$228,616 $65.17 p/Share	3,508 Reduced 6.44%	50,987 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$239,352 $74.31 p/Share	3,221 Reduced 6.13%	49,364 Common Stock

Feb 27 2023	SELL Payment of exercise price or tax liability	$19,384 $85.77 p/Share	226 Reduced 0.51%	44,403 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	20,376 Added 50.0%	20,376 Common Stock (RSU)
May 31 2022	BUY Grant, award, or other acquisition	-	20,671 Added 50.0%	20,671 Common Stock (RSU)
Apr 08 2022	SELL Open market or private sale	$1,780,170 $105.0 p/Share	16,954 Reduced 28.07%	43,453 Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	$860,682 $62.26 p/Share	13,824 Added 21.43%	50,686 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$2,272,301 $101.09 p/Share	22,478 Reduced 32.55%	46,583 Common Stock
Mar 30 2022	SELL Open market or private sale	$559,726 $104.7 p/Share	5,346 Reduced 8.3%	59,071 Common Stock
Mar 30 2022	BUY Exercise of conversion of derivative security	$546,682 $102.26 p/Share	5,346 Added 7.66%	64,417 Common Stock
Mar 17 2022	SELL Open market or private sale	$493,150 $106.65 p/Share	4,624 Reduced 7.26%	59,071 Common Stock
Mar 17 2022	BUY Exercise of conversion of derivative security	$307,647 $104.82 p/Share	2,935 Added 4.52%	62,006 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$14,615 $103.65 p/Share	141 Reduced 0.23%	60,760 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$23,572 $104.3 p/Share	226 Reduced 0.38%	59,394 Common Stock
Feb 21 2022	BUY Grant, award, or other acquisition	-	47,640 Added 44.42%	59,620 Common Stock

PSS

Prem S Shah

EVP and Pres-Pharm, Consumer W

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Value

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS

Account